Clinical Trials Logo

Adrenocortical Hyperfunction clinical trials

View clinical trials related to Adrenocortical Hyperfunction.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05299554 Enrolling by invitation - Clinical trials for Congenital Adrenal Hyperplasia

Long-term Safety Study of Chronocort in the Treatment of Participants With Congenital Adrenal Hyperplasia

Start date: April 1, 2022
Phase: Phase 3
Study type: Interventional

This phase III study is an open-label extension study to be conducted at approximately 21 investigational sites across 3 countries. The study will evaluate the long-term safety and tolerability of Chronocort in participants aged 16 years and over when used as treatment for Congenital Adrenal Hyperplasia (CAH).